# Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes

> **NCT00184600** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 708 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** biphasic insulin aspart
- **DRUG:** insulin detemir
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT00184600
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 708 (ACTUAL)
- **Last updated:** 2017-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00184600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00184600, "Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT00184600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*